Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.460
-0.080 (-5.19%)
At close: Dec 23, 2025, 4:00 PM EST
1.450
-0.010 (-0.68%)
After-hours: Dec 23, 2025, 4:39 PM EST
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,426,778
Market Cap
173.48M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | -5 | -35.71% |
| Dec 31, 2021 | 14 | 3 | 27.27% |
| Dec 31, 2020 | 11 | 3 | 37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TLSA News
- 4 days ago - Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman - GlobeNewsWire
- 6 days ago - Tiziana Life Sciences to Ring the Closing Bell at Nasdaq - GlobeNewsWire
- 6 days ago - Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer's Clinical Trial - GlobeNewsWire
- 8 days ago - Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - GlobeNewsWire
- 8 days ago - Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering - GlobeNewsWire
- 11 days ago - Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial - GlobeNewsWire
- 21 days ago - Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company - GlobeNewsWire
- 4 weeks ago - Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program - GlobeNewsWire